Injective Protocol and Bitoro Network have joined forces to introduce an innovative on-chain perpetual futures platform that is set to be unveiled tomorrow, June 13, at 10 am ET. This partnership aims to offer fast and cost-effective trading options for institutional-grade real-world assets (RWA) and cryptocurrency futures.
Bitoro Network Surpasses 30,000 Users in Just Two Months
In less than two months since its launch, Bitoro Network has already attracted over 30,000 users, with a trading volume exceeding $1 billion. This rapid growth has positioned Bitoro as the fastest-growing decentralized futures exchange in the market. Together, Bitoro and Injective have ambitious plans to establish themselves as the top on and off-chain trading platforms, competing with leading providers based on key features such as fees, speed, and reliability.
The integration of Injective with Bitoro Network significantly enhances the decentralized perpetual futures platform. By leveraging Injective’s robust blockchain infrastructure and unique on-chain order book, Bitoro can now offer new trading pairs with low fees, staking vaults, and tailored solutions for institutional clients.
Through Injective, Bitoro gains access to comprehensive on-chain perpetual markets for a wide range of assets, including real-world assets like forex pairs and commodities. Bitoro also benefits from shared liquidity pools on-chain, resulting in increased market depth and liquidity for trading pairs.
Furthermore, Bitoro can leverage the institutional-quality infrastructure and security measures provided by Injective, allowing institutional clients to comply with global standards and seamlessly integrate with existing trading infrastructure. With over 60 top-tier global institutions securing Injective’s network as validators, Bitoro is well-positioned for growth and success.
Bitoro CEO Brian Purcell Excited for Partnership with Injective
Brian Purcell, the CEO of Bitoro Network, expressed his excitement about the collaboration with Injective. He highlighted how Injective’s architecture enhances Bitoro’s offerings by introducing cutting-edge features like institutional gateways and on-chain perpetuals for RWAs, along with low-cost trading options.
Eric Chen, co-founder and CEO of Injective Labs, also shared his enthusiasm for the partnership, emphasizing how Injective’s plug-and-play modules empower developers to deploy innovative dApps quickly. He looks forward to seeing Bitoro leverage Injective’s on-chain order book and additional features to provide unmatched liquidity and a seamless user experience from the outset.
By teaming up with an established player like Injective, Bitoro is poised to solidify its position as a premier aggregator of continuous liquidity pools. With a trading volume of $1 billion in less than two months since its launch in Q1 2024, Bitoro is gearing up to expand into new markets and offer innovative trading solutions for both retail and institutional traders.
